Entos Pharmaceuticals Inc (Entos), a clinical-stage company that develops genetic medicines utilizing its non-viral, redosable Fusogenix PLV delivery platform is proud to announce a collaboration with ...
Roche is launching a new global phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in ...
PHOENIX - We are learning more about the death of comedian Gilbert Gottfried, which was announced on April 12. According to a statement from Gottfried's longtime friend and publicist, Glenn Schwartz, ...
Roche Holding said it would start a late-stage study for a gene therapy for Duchenne muscular dystrophy to seek approval in the European Union after drug regulators in the bloc turned it down last ...
This summer, shoppers across the U.S. can make a lasting impact for kids and young adults living with neuromuscular diseases. The Muscular Dystrophy Association (MDA) is partnering with more than ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.
Sarepta Therapeutics (SRPT) stock and Roche (RHHBY) stock are in focus as Duchenne therapy Elevidys faces a new late-stage ...
Muscle tissue damage appears when muscular dystrophy is induced in a mouse model (middle). But when researchers block the function of two genes that drive unwanted mitochondrial pore formation (right) ...
Muscular dystrophies represent a group of inherited primary diseases of muscle, characterized by muscle fiber degeneration and muscle weakness. Classification of these conditions has traditionally ...
The FDA expanded the approval of delandistrogene moxeparvovec-rokl (Elevidys) gene therapy for Duchenne muscular dystrophy on Thursday to include ambulatory or non-ambulatory patients ages 4 years and ...
SACRAMENTO (CBS13) — Comedian, actor and filmmaker, Jerry Lewis left behind decades worth of precious moments and laughs through his work on the big screen and in television, but it was his devotion ...